In the immunoblottings, USP4 protein levels were up-regulated to a greater extent in HCC samples (Figure 1D, left); 18 out of 59 patients with HCC (31%) exhibited higher levels of USP4 by at least a two-fold as compared with the corresponding NT. Here, USP4 is linked to hepatocellular carcinoma.